DCAT Value Chain Insights

Clinical Trial Material Supply: Is Change Coming?

The COVID-19 pandemic gave rise to innovation in conducting clinical trials, including decentralized and direct-to-patient services. Will this trend continue, and what may be the impact on clinical...

Mid-Year CDMO Review: COVID-19 Vaccine Manufacturing and M&A

What have been the key developments in 2021 thus far in the CDMO market? Increasing participation by CDMOs in COVID-19 vaccine manufacturing and robust mergers and acquisition activity have marked...

SPONSORED CONTENT

Managing Manufacturing in Times of Uncertainty

Information
June 16, 2021
Sponsored by CMIC CMO USA

Virtual pharmaceutical companies often have strong regulatory and clinical teams, but lack the resources needed to address the complexities of the complete product development and commercialization...

Read More
Exploring Ultra-Low Temperature Packaging Solutions for Gene Therapies

Information
June 9, 2021
Sponsored by Almac

With the industry moving to more personalized medicine and delivering genetic material to patients to treat conditions resulting from genetic mutations, we speak to Sean Canavan, Operations Manager...

Read More
Planning for Success, Addressing Quality Early for Gene Therapies

Information
June 2, 2021
Sponsored by Catalent Biologics

The approvals of Roche’s Luxturna® (2017) for inherited retinal disease and Novartis’ Zolgensma® (2019) for spinal muscular atrophy are indicative of a resurgence in the gene therapy field after a...

Read More